Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation

Blood

Volumn 91, Issue 10, 1998, Pages 3654-3661

  Lucas, Kenneth G ^b   Burton, Robert L ^b   Zimmerman, Sarah E ^b   Wang, Jinghong ^b   Cornetta, Kenneth G ^b   Robertson, Kent A ^b   Lee, Chao H ^b   Emanuel, David J ^a  

^a RILEY HOSPITAL FOR CHILDREN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADOPTIVE TRANSFER; ADULT; ARTICLE; CELL TRANSFORMATION; CHILD; EPSTEIN BARR VIRUS; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; LYMPHOBLASTOID CELL; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; STEM CELL TRANSPLANTATION; VIRUS GENOME; VIRUS INDUCTION;

EID: 0032525146     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.10.3654     Document Type: Article

References (40)

1. Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P, Pecora A, Gillio A, Kernan NA, O'Reilly RJ: Immune reconstitution following bone marrow transplantation: Comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 73:1340, 1989
2. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, Young JW, Kernan NA, O'Reilly RJ: Infusions of donor leukocytes as treatment of Epstein-Barr virus associated lymphoproliferative disorders complicating allogeneic marrow transplantation. N Engl J Med 330:1185, 1994
3. Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, Durnam DM: Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520, 1988
4. Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, Arthur DC, Patton DF, Greenberg JS, Burke B, Ramsay NKC, McGlave P, Filipovich AH: Epstein-Barr virus associated B-cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234, 1988
5. Lucas KG, Small TN, Heller G, Dupont B, O'Reilly RJ: The development of cellular immunity to Epstein-Barr virus following allogeneic bone marrow transplantation. Blood 87:2594, 1996
6. Tosato G: The Epstein-Barr virus and the immune system. Adv Cancer Res 49:75, 1987
7. Antin J, Bierer B, Smith B, Ferrara J, Guinan EC, Sieff C, Golan DE, Macklis RM, Tarbell NJ, Lynch E, Reichert TA, Blythman H, Bouloux C, Rappeport JM, Burakoff SJ, Weinstein HJ: Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: Effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies. Blood 78:2139, 1991
8. Martin PJ, Shulman HM, Scubach WH, Hansen JA, Fefer A, Miller G, Thomas ED: Fatal Epstein-Barr virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody. Ann Intern Med 101:310, 1984
9. Shapiro RS, Chauvenet A, McGuire W, Pearson A, Craft AW, McGlave P, Filipovich A: Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin. N Engl J Med 318:1334, 1988
10. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Balfour HH Jr, Simmons RL, Najarian JS: Acyclovir therapy of Epstein-Barr virus-induced post-transplant lymphoproliferative diseases. Transplant Proc 17:89, 1985
11. Fischer A, Blanche S, LeBidois J, Bordigon P, Garnie JN, Niaude P, Moune F, LeDiest F, Fischer AM, Griscali C, Hirn M: Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324:1451, 1991
12. Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE: Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345:9, 1995
13. Kenagy DN, Schlesinger Y, Weck K, Kitter JH, Gaudreault-Kenner MM, Storch GA: Epstein-Barr virus DNA in peripheral blood leukocytes of patients with post-transplant lymphoproliferative disease. Transplant 60:547, 1995
14. Riddler SA, Breinig MC, McKnight JK: Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of post-transplant lymphoproliferative disease in solid-organ transplant recipients. Blood 84:972, 1994
15. Savoie A, Perpete C, Carpentier L, Joncas J, Alfieri C: Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 83:2715, 1994
16. Rooney CM, Loftin SK, Holladay MS, Brenner MK. Krance RA, Heslop HE: Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematol 89:98, 1995
17. Reisner Y, Freidrich W, Fabian IA: A shorter procedure of preparation of E-rosette bone marrow for transplantation. Transplant 42:312, 1986
18. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Thomas ED: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729, 1986.
19. Uhara H, Sato Y, Mukai K, Akao I, Matsuno Y, Furuya S, Hoshikawa T, Shimosato Y, Saida T: Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin's disease using the polymerase chain reaction and in situ hybridization. Japan J Cancer Res 81:272, 1990
20. Taswell C: Limiting dilution analysis for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol Methods 72:29, 1984
21. Metzenberg S: Levels of Epstein-Barr virus DNA in lymphoblastoid cell lines are correlated with frequencies of spontaneous lytic growth but not with levels of expression of EBNA-1, EBNA-2, or latent membrane protein. J Virol 64:437, 1990
22. Lewin N, Aman P, Masucci MG, Klein E, Klein G, Oberg B, Strander H, Henle W, Henle G: Characterization of EBV-carrying B-cell populations in healthy sero-positive individuals with regard to density, release of transforming virus and spontaneous outgrowth. Int J Cancer 39:472, 1987
23. Aman P, Ehlin-Henriksson B, Klein G: Epstein-Barr virus susceptibility of normal human B lymphocyte populations. J Exp Med 159:208, 1984
24. Katz BZ, Saini U: Presence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoproliferative disorders. Am J Pathol 140:1247, 1992
25. Crawford DH, Mulholland N, Iliescu V, Hawkins R, Powles R: Epstein-Barr virus infection and immunity in bone marrow transplant recipients. Transplant 42:50, 1986
26. Strang G, Rickinson AB: Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis. Eur J Immunol 17:1007, 1987
27. Klein E, Ernberg I, Mascucci MG, Szigeti R, Wu YT, Mascucci G, Svedmyr E: T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis. Cancer Res 41:4210, 1981
28. Rickinson AB, Moss DJ, Wallace LE, Rowe M, Misko IS, Epstein MA, Pope JH: Long-term T-cell-mediated immunity to Epstein-Barr virus. Cancer Res 41:4216, 1981
29. Wallace L, Rowe M, Rickinson AB, and Epstein MA: Cytotoxic T recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2. Eur J Immunol 12:1012, 1982
30. Murray RJ, Kurilla MG, Griffin HH, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E, Rickinson AB: Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. Proc Natl Acad Sci USA 87:2906, 1990
31. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB: Identification of target antigens for the human cytotoxic T-cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies. J Exp Med 176:157, 1992
32. Imashuku S, Goto T, Matsunaga T, Naya M, Yamori M, Hojo M, Hibi S, Todo S: Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD). Bone Marrow Transpl 20:337, 1997
33. Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Fefer A, Fisher L, Buckner CD, Anasetti C, Appelbaum FR, Badger C: Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73:1720, 1989
34. Slavin S, Naparstek E, Nagler A, Ackerstein A, Samuel S, Kapelushnik J, Brautbar C, Or R: Allogeneic cell therapy with donor peripheral blood cells and recombinant human Interleukin-2 to treat leukemia relapse. Blood 87:2195, 1996
35. Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F, Castro-Malaspina H, Childs BH, Gillio AP, Kernan NA, O'Reilly RJ: Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft vs. leukemia responses from graft vs. host disease. Blood 86:1261, 1995
36. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwiesser D, vanRhee F, Mittermueller J, de Witte T, Holler E, Ansari H: Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86:2041, 1995
37. Knowles DM, Cesarman E, Chadburn A, Frizerra G, Chen J, Rose EA, Michler RE: Correlative morphologic and genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552, 1995
38. Knowles DM: Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. Hematol/Oncol Clin North Am 10:1081, 1996
39. Gaidano G, Pastore C, Lanza C, Mazza U, Saglio G: Molecular pathology of AIDS-related lymphomas. Biologic aspects and clinicopathologic heterogeneity. Ann Hematol 69:281, 1994
40. Carbone A, Dolcetti R, Gloghini A, Maestro R, Vaccher E, DiLuca D, Tirelli U, Boiocchi M: Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: A comparative study. Human Pathol 27:133, 1996